Elekta Linear Accelerator (MR)

Device Elekta Limited
Total Payments
$2.3M
Transactions
39
Doctors
0
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2020 $385,326 12 0
2019 $1.4M 18 0
2017 $515,135 9 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.3M 39 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
MR linac research program Elekta Limited $684,714 0
Adaptive RT imaging, planning, monitoring Elekta Limited $484,532 0
MR guided radiotherapy Elekta Limited $200,901 0
MOMENTUM Elekta Limited $172,124 0
Coordination of joint clinical research within MRL Consortium Elekta Limited $143,095 0
Adaptive correction strategies for intra- and inter-fraction variability Elekta Limited $125,000 0
MRL consortium clinical coordination Elekta Limited $114,404 0
MRL registry project management (MOMENTUM) Elekta Limited $101,922 0
Towards dosimetry commissioning of MR Linac Elekta Limited $55,523 0
Gel dosimetry for MR Linac Elekta Limited $33,805 0
Variable margin expansion to account for MR distortion Elekta Limited $33,628 0
MR-guided motion management Elekta Limited $28,445 0
MRI simulation in treatment position for spinal SBRT Elekta Limited $27,044 0
MRL auto-segmentation Elekta Limited $25,284 0
MR guided radiotherapy for pancreatic cancer Elekta Limited $25,000 0
Adaptive correction strategies for intra- and inter-fraction variability Elekta, Inc. $16,169 0

Top Doctors Receiving Payments for Elekta Linear Accelerator (MR)

Doctor Specialty Location Total Records
Unknown Milwaukee, WI $2.3M 39

About Elekta Linear Accelerator (MR)

Elekta Linear Accelerator (MR) is a device associated with $2.3M in payments to 0 healthcare providers, recorded across 39 transactions in the CMS Open Payments database. The primary manufacturer is Elekta Limited.

Payment data is available from 2017 to 2020. In 2020, $385,326 was paid across 12 transactions to 0 doctors.

The most common payment nature for Elekta Linear Accelerator (MR) is "Unspecified" ($2.3M, 100.0% of total).

Elekta Linear Accelerator (MR) is associated with 16 research studies, including "MR linac research program" ($684,714).